Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Starts Vaxcyte (PCVX) at Overweight
-
Cantor Fitzgerald Starts Merck (MRK) at Neutral
-
Cantor Fitzgerald Starts Eli Lilly (LLY) at Overweight
-
Cantor Fitzgerald Assumes Gilead Sciences (GILD) at Overweight
-
Cantor Fitzgerald Starts Bristol-Myers Squibb Co. (BMY) at Neutral
-
Cantor Fitzgerald Assumes Amgen (AMGN) at Neutral
-
Cantor Fitzgerald Starts Abbvie (ABBV) at Overweight
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Mar 31
-
Form EFFECT Cantor Fitzgerald Income
-
Cantor Fitzgerald Reiterates Overweight Rating on Roivant Sciences (ROIV)
-
Cantor Fitzgerald Reiterates Overweight Rating on Meta Platforms Inc. (META)
-
Cantor Fitzgerald Reiterates Neutral Rating on Alphabet (GOOGL)
-
Cantor Fitzgerald Reiterates Neutral Rating on Lyft (LYFT)
-
Cantor Fitzgerald Reiterates Neutral Rating on Texas Instruments (TXN)
-
Lam Research (LRCX) PT Lowered to $90 at Cantor Fitzgerald
-
Intel (INTC) PT Lowered to $20 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on ServiceNow (NOW)
-
Cantor Fitzgerald Reiterates Overweight Rating on aTyr Pharma (ATYR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Anteris Technologies Global (AVR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Nano-X Imaging (NNOX)
-
Cantor Fitzgerald Starts Verona Pharma (VRNA) at Overweight
-
Form POS AM Cantor Fitzgerald Income
-
Satellogic Announces Closing of $20 Million Registered Direct Offering of Class A Common Stock
-
Cantor Fitzgerald Reiterates Overweight Rating on Uber Inc. (UBER)
-
Spotify (SPOT) PT Lowered to $520 at Cantor Fitzgerald
-
Shopify (SHOP) PT Lowered to $80 at Cantor Fitzgerald
-
Meta Platforms Inc. (META) PT Lowered to $624 at Cantor Fitzgerald
-
MercadoLibre (MELI) PT Lowered to $2,400 at Cantor Fitzgerald
-
Alphabet (GOOGL) PT Lowered to $159 at Cantor Fitzgerald
-
DoorDash Inc. (DASH) PT Lowered to $210 at Cantor Fitzgerald
-
Booking Holdings (BKNG) PT Lowered to $4,330 at Cantor Fitzgerald
-
Cantor Fitzgerald lowers Amazon (AMZN) price target to $230.00
-
Airbnb Inc. (ABNB) PT Lowered to $101 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on ServiceNow (NOW)
-
Cantor Fitzgerald Reiterates Overweight Rating on NVIDIA (NVDA)
-
Form 424B3 Cantor Fitzgerald Income
-
Just Week Away! Washington D.C.-area C-suite executives invited to HMG Strategy’s 14th Annual Washington D.C. C-Level Technology Leadership Summit of America on April 22
-
Cantor Fitzgerald Reiterates Overweight Rating on Cidara Therapeutics (CDTX)
-
Applied Blockchain Inc (APLD) PT Lowered to $7 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on TruBridge Inc (TBRG)
-
Cantor Fitzgerald Reiterates Overweight Rating on Health Catalyst Inc. (HCAT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Zai Lab (ZLAB)
-
Cantor Fitzgerald Upgrades Verve Therapeutics (VERV) to Overweight, 'We're Impressed by VERVE-102'
-
Verve Therapeutics (VERV) Surges 10pct Premarket on Cantor Upgrade, Bullish Commentary, Updated News
-
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor
-
Hive Digital Technologies (HIVE) PT Lowered to $4 at Cantor Fitzgerald
-
Core Scientific Inc. (CORZ) PT Lowered to $16 at Cantor Fitzgerald
-
Cipher Mining (CIFR) PT Lowered to $4 at Cantor Fitzgerald
-
Bitdeer Technologies Group (BTDR) PT Lowered to $13 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Rocket Lab USA (RKLB)

